<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39451771</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1718-7729</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Current oncology (Toronto, Ont.)</Title><ISOAbbreviation>Curr Oncol</ISOAbbreviation></Journal><ArticleTitle>Timely Treatment and No Change in Thyroid Cancer Mortality During COVID-19 Pandemic. Reply to Nocini et al. No Impact of COVID-19 Pandemic on Early Mortality for Thyroid Cancer in the US. Comment on "Lee et al. Impact of the COVID-19 Pandemic on Thyroid Cancer Surgery. <i>Curr. Oncol.</i> 2024, <i>31</i>, 3579-3590".</ArticleTitle><Pagination><StartPage>6270</StartPage><EndPage>6271</EndPage><MedlinePgn>6270-6271</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/curroncol31100467</ELocationID><Abstract><AbstractText>We thank Nocini et al [...].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Max L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0003-3526-288X</Identifier><AffiliationInfo><Affiliation>Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Michelle M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-6988-5658</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology--Head &amp; Neck Surgery, Stanford University, Palo Alto, CA 94304, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Oncol</MedlineTA><NlmUniqueID>9502503</NlmUniqueID><ISSNLinking>1198-0052</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Curr Oncol. 31:6267.</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013964" MajorTopicYN="Y">Thyroid Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39451771</ArticleId><ArticleId IdType="pmc">PMC11505981</ArticleId><ArticleId IdType="doi">10.3390/curroncol31100467</ArticleId><ArticleId IdType="pii">curroncol31100467</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee M.L., Megwalu U.C., Finegersh A., Noel J.E., Chen M.M. Impact of the COVID-19 Pandemic on Thyroid Cancer Surgery. Curr. Oncol. 2024;31:3579–3590. doi: 10.3390/curroncol31060263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/curroncol31060263</ArticleId><ArticleId IdType="pmc">PMC11202414</ArticleId><ArticleId IdType="pubmed">38920746</ArticleId></ArticleIdList></Reference><Reference><Citation>Nocini R., Lippi G., Mattiuzzi C. No Impact of COVID-19 Pandemic on Early Mortality for Thyroid Cancer in the US. Comment on Lee et al. Impact of the COVID-19 Pandemic on Thyroid Cancer Surgery. Curr. Oncol. 2024, 31, 3579–3590. Curr. Oncol. 2024;31:6267–6269. doi: 10.3390/curroncol31100466.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/curroncol31100466</ArticleId><ArticleId IdType="pubmed">39451770</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>